If you experienced surprising symptoms that led to a cancer diagnosis, feel free to tell your story using this anonymous form ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

The FDA designates ofirnoflast as an orphan drug, highlighting its innovative approach to treating myelodysplastic syndromes ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved ...

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

Fifteen-year-old Isabella Harris has a lot going for her. She’s a talented dancer and a dedicated student, but right now ...

Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Key Takeaways An already approved drug might help kids with a rare bone cancerPazopanib extended survival in a small group of ...